Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("JANES, Jonathan")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 8 of 8

  • Page / 1
Export

Selection :

  • and

Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)LEVI, Marcel; LEVY, Mitchell; SUNDIN, David P et al.American journal of respiratory and critical care medicine. 2007, Vol 176, Num 5, pp 483-490, issn 1073-449X, 8 p.Article

Drotrecogin Alfa (Activated) in Adults with Septic ShockMARCO RANIERI, V; TAYLOR THOMPSON, B; PAYEN, Didier et al.The New England journal of medicine. 2012, Vol 366, Num 22, pp 2055-2064, issn 0028-4793, 10 p.Article

Underlying disorders and their impact on the host response to infectionDHAINAUT, Jean-Francois; CLAESSENS, Yann-Erick; JANES, Jonathan et al.Clinical infectious diseases. 2005, Vol 41, pp S481-S489, issn 1058-4838, SUP7Conference Paper

Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shockDHAINAUT, Jean-Francois; ANTONELLI, Massimo; MIGNINI, Mariano A et al.Intensive care medicine (Print). 2009, Vol 35, Num 7, pp 1187-1195, issn 0342-4642, 9 p.Article

Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE : Further evidence for survival and safety and implications for early treatmentVINCENT, Jean-Louis; BERNARD, Gordon R; WONG, Kar et al.Critical care medicine. 2005, Vol 33, Num 10, pp 2266-2277, issn 0090-3493, 12 p.Article

Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia : a comparative study of insulin lispro and regular human insulinFERGUSON, Stewart C; STRACHAN, Mark W. J; JANES, Jonathan M et al.Diabetes/metabolism research and reviews (Print). 2001, Vol 17, Num 4, pp 285-291, issn 1520-7552Article

ADDRESS (ADministration of DRotrecogin alfa [activated] in early stage severe sepsis) long-term follow-up: One-year safety and efficacy evaluationLATERRE, Pierre-Francois; ABRAHAM, Edward; JANES, Jonathan M et al.Critical care medicine. 2007, Vol 35, Num 6, pp 1457-1463, issn 0090-3493, 7 p.Article

Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trialDHAINAUT, Jean-Francois; LATERRE, Pierre-Francois; VINCENT, Jean-Louis et al.Intensive care medicine (Print). 2003, Vol 29, Num 6, pp 894-903, issn 0342-4642, 10 p.Article

  • Page / 1